259 related articles for article (PubMed ID: 36676643)
1. Pregnancy and Lactation-Associated Osteoporosis Successfully Treated with Romosozumab: A Case Report.
Kaneuchi Y; Iwabuchi M; Hakozaki M; Yamada H; Konno SI
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676643
[TBL] [Abstract][Full Text] [Related]
2. Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: A case study.
Ijuin A; Yoshikata H; Asano R; Tsuburai T; Kikuchi R; Sakakibara H
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):863-866. PubMed ID: 29241936
[TBL] [Abstract][Full Text] [Related]
3. Case report: Teriparatide treatment in a case of severe pregnancy -and lactation- associated osteoporosis.
Lampropoulou-Adamidou K; Trovas G; Stathopoulos IP; Papaioannou NA
Hormones (Athens); 2012; 11(4):495-500. PubMed ID: 23422774
[TBL] [Abstract][Full Text] [Related]
4. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures.
Choe EY; Song JE; Park KH; Seok H; Lee EJ; Lim SK; Rhee Y
J Bone Miner Metab; 2012 Sep; 30(5):596-601. PubMed ID: 22105654
[TBL] [Abstract][Full Text] [Related]
5. Bone Density After Teriparatide Discontinuation With or Without Antiresorptive Therapy in Pregnancy- and Lactation-Associated Osteoporosis.
Lee S; Hong N; Kim KJ; Park CH; Lee J; Rhee Y
Calcif Tissue Int; 2021 Nov; 109(5):544-553. PubMed ID: 34037833
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis.
Li LJ; Zhang J; Gao P; Lv F; Song YW; Chang XY; Zhao DC; Wang O; Jiang Y; Xing XP; Xia WB; Li M
Clin Rheumatol; 2018 Nov; 37(11):3141-3150. PubMed ID: 29946989
[TBL] [Abstract][Full Text] [Related]
7. Effect of Teriparatide on Subsequent Fracture and Bone Mineral Density in 47 Women with Pregnancy- and Lactation-associated Osteoporosis and Vertebral Fractures.
Hadji P; Mouzakiti N; Kyvernitakis I
Geburtshilfe Frauenheilkd; 2022 Jun; 82(6):619-626. PubMed ID: 35903718
[No Abstract] [Full Text] [Related]
8. Effectiveness of romosozumab in patients with osteoporosis at high fracture risk: a Japanese real-world study.
Miyauchi A; Hamaya E; Shimauchi J; Yoshinaga Y; Nishi K
J Bone Miner Metab; 2024 Jan; 42(1):77-89. PubMed ID: 38086988
[TBL] [Abstract][Full Text] [Related]
9. Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis.
Stumpf U; Kraus M; Hadji P
Osteoporos Int; 2021 Nov; 32(11):2383-2387. PubMed ID: 34041561
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy- and lactation-induced osteoporosis: a social-media-based survey.
Peltz-Sinvani N; Raz HM; Klein P; Ish-Shalom S; Vered I; Tripto-Shkolnik L
BMC Pregnancy Childbirth; 2023 May; 23(1):311. PubMed ID: 37131133
[TBL] [Abstract][Full Text] [Related]
11. A case of pregnancy and lactation associated osteoporosis in the third pregnancy; robust response to teriparatide despite delayed administration.
Cerit ET; Cerit M
Bone Rep; 2020 Dec; 13():100706. PubMed ID: 32884982
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of severe pregnancy and lactation-related osteoporosis with teriparatide: case report and review of the literature.
Polat SB; Evranos B; Aydin C; Cuhaci N; Ersoy R; Cakir B
Gynecol Endocrinol; 2015 Jul; 31(7):522-5. PubMed ID: 25893268
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of anti-osteoporosis medications in preventing vertebral body fractures after balloon kyphoplasty.
Ueno M; Tajima Y; Ito S; Tsuji M; Toriumi E; Yoshii A; Otake N; Tanaka H
Arch Osteoporos; 2024 Mar; 19(1):19. PubMed ID: 38512565
[TBL] [Abstract][Full Text] [Related]
14. Bone Microarchitecture and Strength Changes During Teriparatide and Zoledronic Acid Treatment in a Patient with Pregnancy and Lactation-Associated Osteoporosis with Multiple Vertebral Fractures.
Treurniet S; Bevers MSAM; Wyers CE; Micha D; Teunissen BP; Elting MW; van den Bergh JP; Eekhoff EMW
Calcif Tissue Int; 2023 May; 112(5):621-627. PubMed ID: 36764958
[TBL] [Abstract][Full Text] [Related]
15. Romosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density.
Poole KE; Treece GM; Pearson RA; Gee AH; Bolognese MA; Brown JP; Goemaere S; Grauer A; Hanley DA; Mautalen C; Recknor C; Yang YC; Rojeski M; Libanati C; Whitmarsh T
J Bone Miner Res; 2022 Feb; 37(2):256-264. PubMed ID: 34738660
[TBL] [Abstract][Full Text] [Related]
16. Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis.
Hong N; Kim JE; Lee SJ; Kim SH; Rhee Y
Clin Endocrinol (Oxf); 2018 May; 88(5):652-658. PubMed ID: 29389010
[TBL] [Abstract][Full Text] [Related]
17. Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis.
Chen P; Miller PD; Delmas PD; Misurski DA; Krege JH
J Bone Miner Res; 2006 Nov; 21(11):1785-90. PubMed ID: 17002571
[TBL] [Abstract][Full Text] [Related]
18. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
19. Teriparatide Treatment in Patients with Pregnancy- and Lactation-Associated Osteoporosis.
Lampropoulou-Adamidou K; Trovas G; Triantafyllopoulos IK; Yavropoulou MP; Anastasilakis AD; Anagnostis P; Toulis KA; Makris K; Gazi S; Balanika A; Tournis S
Calcif Tissue Int; 2021 Nov; 109(5):554-562. PubMed ID: 34132853
[TBL] [Abstract][Full Text] [Related]
20. Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension.
Miyauchi A; Dinavahi RV; Crittenden DB; Yang W; Maddox JC; Hamaya E; Nakamura Y; Libanati C; Grauer A; Shimauchi J
Arch Osteoporos; 2019 Jun; 14(1):59. PubMed ID: 31168657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
